Shuanghu Wang

3.8k total citations · 1 hit paper
177 papers, 3.0k citations indexed

About

Shuanghu Wang is a scholar working on Molecular Biology, Pharmacology and Biomedical Engineering. According to data from OpenAlex, Shuanghu Wang has authored 177 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 50 papers in Pharmacology and 27 papers in Biomedical Engineering. Recurrent topics in Shuanghu Wang's work include Pharmacogenetics and Drug Metabolism (32 papers), Micro and Nano Robotics (19 papers) and Nanoplatforms for cancer theranostics (13 papers). Shuanghu Wang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (32 papers), Micro and Nano Robotics (19 papers) and Nanoplatforms for cancer theranostics (13 papers). Shuanghu Wang collaborates with scholars based in China, Netherlands and United States. Shuanghu Wang's co-authors include Yingfeng Tu, Fei Peng, Peiwu Geng, Kun Liu, Juanfeng Ou, Fei Wang, Yicheng Ye, Jiamiao Jiang, Yunfang Zhou and Junbin Gao and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Shuanghu Wang

170 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent advances in molecular mechanisms of skin wound healing and its treatments

2024 89 citations Peiwu Geng, Shuanghu Wang et al. profile →

Peers

Shuanghu Wang

CMP

PHARM

ONCOL

Weiwei Qin China

Guoan Luo China

Hiroshi Masumoto Japan

Wen Huang China

Tao Yi China

Masahiro Nakano Japan

Tatsuki Fukami Japan

V. Jayalakshmi India

W. Rieß Switzerland

Osamu Wada Japan

Weiwei Qin China

Shuanghu Wang

656 ×0.7

1.4k ×1.9

85 ×0.1

CMP

105 ×0.2

PHARM

221 ×0.7

ONCOL

Citations per year, relative to Shuanghu Wang Shuanghu Wang (= 1×) peers Weiwei Qin

Countries citing papers authored by Shuanghu Wang

Since Specialization

Citations

This map shows the geographic impact of Shuanghu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuanghu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuanghu Wang more than expected).

Fields of papers citing papers by Shuanghu Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuanghu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuanghu Wang. The network helps show where Shuanghu Wang may publish in the future.

Co-authorship network of co-authors of Shuanghu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuanghu Wang. A scholar is included among the top collaborators of Shuanghu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuanghu Wang. Shuanghu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Younas, Ayesha, Shuanghu Wang, Muhammad Asad, et al.. (2025). Recent advances in cancer nanomedicine: From smart targeting to personalized therapeutics - pioneering a new era in precision oncology. Materials Today Bio. 36. 102660–102660.

Molla, Abul Hossain, M. Nazmul Hoque, Fahmida Tasnim Richi, et al.. (2025). Biosynthesis and Characterization of ZnO Nanoparticles Using Citrus reticulata Peel Followed by Photocatalytic, Antibacterial, and Antioxidative Nanotherapeutic Attributes Assessment Supported by Computer Simulation. International Journal of Nanomedicine. Volume 20. 4803–4829. 6 indexed citations

Li, Yueting, Shaojun Du, Youjun Feng, et al.. (2025). Nitric Oxide‐Enhanced Chitosan‐Based Nanoparticles for Dual‐Mode Photothermal and Photodynamic Therapy in Infected Wounds. Advanced Healthcare Materials. 15(4). e02584–e02584.

Mamun, Abdullah Al, et al.. (2024). Targeting Remyelination in Spinal Cord Injury: Insights and Emerging Therapeutic Strategies. CNS Neuroscience & Therapeutics. 30(12). 1–15. 4 indexed citations

Shao, Chuxiao, et al.. (2024). Recent advances in the role of neuroregulation in skin wound healing. Burns & Trauma. 13. tkae072–tkae072. 1 indexed citations

Wei, Shiqiang, Shuanghu Wang, Hua Chen, et al.. (2024). Asymmetric Intramolecular Amination Catalyzed with Cp*Ir-SPDO via Nitrene Transfer for Synthesis of Spiro-Quaternary Indolinone. Journal of the American Chemical Society. 146(28). 18841–18847. 12 indexed citations

Mamun, Abdullah Al, Peiwu Geng, Shuanghu Wang, & Chuxiao Shao. (2024). Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation. Journal of Inflammation Research. Volume 17. 7037–7056. 3 indexed citations

Zhang, Qing, Shuanghu Wang, Lili Zou, et al.. (2023). Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects. Frontiers in Endocrinology. 14. 6 indexed citations

Jiang, Jiamiao, Fei Wang, Wei‐Chang Huang, et al.. (2023). Mobile mechanical signal generator for macrophage polarization. SHILAP Revista de lepidopterología. 3(2). 20220147–20220147. 27 indexed citations

10.

Xia, Mengming, Yu Wang, Peiwu Geng, et al.. (2023). Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC‐MS/MS. Thoracic Cancer. 14(33). 3331–3341. 3 indexed citations

11.

Liu, Lu, Shuanghu Wang, Hao Tian, et al.. (2023). Nanorobot-Mediated Synchronized Neuron Activation. ACS Nano. 17(14). 13826–13839. 9 indexed citations

12.

Wu, Qingjun, Shuanghu Wang, Jian Liu, et al.. (2022). Polymorphic mutations in the polb gene promoter and their impact on transcriptional activity. Thoracic Cancer. 13(6). 853–857. 2 indexed citations

13.

Wang, Guozhen, et al.. (2021). Macrophagic Extracellular Vesicle CXCL2 Recruits and Activates the Neutrophil CXCR2/PKC/NOX4 Axis in Sepsis. The Journal of Immunology. 207(8). 2118–2128. 45 indexed citations

14.

Ou, Juanfeng, Hao Tian, Junbin Gao, et al.. (2021). MnO₂-Based Nanomotors with Active Fenton-like Mn²⁺ Delivery for Enhanced Chemodynamic Therapy. ACS Applied Materials & Interfaces. 13(32). 38050–38060. 126 indexed citations

15.

Zhang, Yujie, Xueying Tan, Nan Wang, et al.. (2021). An AIEgen-based photosensitizer for lysosome imaging and photodynamic therapy in tumor. Sensors and Actuators B Chemical. 335. 129698–129698. 24 indexed citations

16.

Wang, Bo, Feifei Chen, Yunfang Zhou, et al.. (2020). Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS. International Journal of Analytical Chemistry. 2020. 1–6. 1 indexed citations

17.

Wang, Zhen, Shuanghu Wang, Kun Liu, et al.. (2020). Water powered and anti-CD3 loaded mg micromotor for t cell activation. Applied Materials Today. 21. 100839–100839. 18 indexed citations

18.

Zhou, Yunfang, et al.. (2020). Inhibitory Effect of Lygodium Root on the Cytochrome P450 3A Enzyme in vitro and in vivo. Drug Design Development and Therapy. Volume 14. 1909–1919. 9 indexed citations

19.

Chen, Feifei, Hui Jiang, Shuanghu Wang, et al.. (2020). In Vitro and In Vivo Rat Model Assessments of the Effects of Vonoprazan on the Pharmacokinetics of Venlafaxine. Drug Design Development and Therapy. Volume 14. 4815–4824. 10 indexed citations

20.

Cheng, Binbin, Yichang Ren, Xiaoge Niu, et al.. (2020). Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death–Ligand 1 Interaction as Potential Anticancer Agents. Journal of Medicinal Chemistry. 63(15). 8338–8358. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact